You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 155 No. 17, 25 SEPTEMBER 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Chronic Fatigue, Fibromyalgia, and Chemical Sensitivity: Overlapping Disorders

Grace Ziem, MD, DrPH; Albert Donnay, MHS
Baltimore, Md

Arch Intern Med. 1995;155(17):1913.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In "Comparison of Patients With Chronic Fatigue Syndrome, Fibromyalgia, and Multiple Chemical Sensitivities,"1 Buchwald and Garrity's data and analysis are weakened by their definition of multiple chemical sensitivity (MCS), which is based on a most atypical choice of "typical" symptoms. The four "respiratory complaints characteristic of MCS"1 that they selected for comparison purposes—from an outdated article with an anti-MCS bias2—were reported by only 22% to 47% of their patients with MCS. The four (unreferenced) neuropsychological symptoms they selected showed a better correlation—two at 67% and two at 90%—but even these fall short of the hallmark correlations that define fibromyalgia (FM) (97% with myalgia) and chronic fatigue syndrome (CFS) (100% with chronic fatigue).

In keeping with the Cullen3 definition cited by Buchwald and Garrity, the hallmark symptom of MCS that the authors should have included in their prevalence analysis (Table 21) is "sensitivity to multiple . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.